INDIA – Lack of access to technology ‘hampers detection of substandard drugs’.
JAPAN – Daiichi Sankyo announces development of nucleic acid treatment for Duchenne muscular dystrophy utilizing proprietary technology.
SINGAPORE – IBN creates unlimited source of human kidney cells.
SINGAPORE – Dyesol and Singapore's NTU sign agreement.
THE PHILIPPINES – Global biotech/GM crop plantings increase 100-fold from 1996.
AUSTRALIA – Phosphagenics further expands pain portfolio.
AUSTRALIA – Primary Health Care signs Australia distribution agreement for iGeneScreen™ prenatal test.
AUSTRALIA – Folic acid in pregnancy linked with reduced autism risk.
AUSTRALIA – Phylogica and Bio-Link collaborate to commercialize anti-inflammatory Phylomers.
AUSTRALIA – ABRAXANE® plus gemcitabine improves survival in Phase III study of patients with advanced pancreatic cancer.
CANADA – Verisante Technology, Inc. announces first sales of aura, a revolutionary medical device for the detection of skin cancer.
EUROPE – Project eyes robust medical technology for poor countries.
UNITED KINGDOM – Asthma sufferers have more lung fungi.
UNITED KINGDOM – Pioneering drug discovery gets major funding to move to next stage.
UNITED STATES – Gilead's sofosbuvir for hepatitis C meets primary endpoint in fourth pivotal Phase III study.
UNITED STATES – Eleven Biotherapeutics publishes data on EBI-005, a novel IL-1 inhibitor protein for topical treatment of dry eye disease.
UNITED STATES – Phase I/II trial of ADXS-HPV in anal cancer conducted by Brown University Oncology Group.
UNITED STATES – Scopolamine: An old drug with new psychiatric applications.
UNITED STATES – New bioengineered ears look and act like the real thing.
UNITED STATES – To trap a rainbow, slow down light.
UNITED STATES – AB SCIEX responds to milk contamination concerns with new method to detect dicyandiamide.
